Css LLC Bio N Tech Se Put Options Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $2.76 Million - $4.17 Million	-22,400 Reduced 69.14%	10,000 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $346,624 - $580,032	-1,600 Reduced 4.71%	32,400 $8.35 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $4.32 Million - $9.39 Million	21,000 Added 161.54%	34,000 $9.28 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $838,568 - $1.79 Million	7,400 Added 132.14%	13,000 $2.91 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $480,088 - $669,200	5,600 New	5,600 $611,000

Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $1.35 Million - $2.41 Million	-18,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $52,029 - $93,753	900 Added 5.08%	18,600 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $682,866 - $1.18 Million	17,700 New	17,700 $1.18 Million

328

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $20.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.